Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 245483, 8 pages
http://dx.doi.org/10.1155/2014/245483
Research Article

Seroprevalence of Antibodies against Pkn1, a Novel Potential Immunogen, in Chlamydia trachomatis-Infected Macaca nemestrina and Human Patients

1Dr BR Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India
2Bhaskaracharya College of Applied Sciences, University of Delhi, Delhi 110075, India
3University of Washington, Seattle, WA 98195-6460, USA

Received 28 February 2014; Accepted 24 May 2014; Published 18 June 2014

Academic Editor: Andrew Horne

Copyright © 2014 Achchhe L. Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, World Health Organization Department of Reproductive Health and Research, 2012.
  2. J. F. Peipert, “Clinical practice. Genital chlamydial infections,” The New England Journal of Medicine, vol. 349, no. 25, pp. 2424–2430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. Wallace, A. Scoular, G. Hart, M. Reid, P. Wilson, and D. J. Goldberg, “What is the excess risk of infertility in women after genital chlamydia infection? A systematic review of the evidence,” Sexually Transmitted Infections, vol. 84, no. 3, pp. 171–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. C. Brunham and J. Rey-Ladino, “Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine,” Nature Reviews Immunology, vol. 5, no. 2, pp. 149–161, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. U. Igietseme and C. M. Black, “Chlamydia vaccine development,” in Chlamydial Infection: A Clinical and Public Health Perspective, vol. 7, pp. 115–130, Karger, Basel, Switzerland, 2013. View at Publisher · View at Google Scholar
  6. G. Christiansen and S. Birkelund, “Is a Chlamydia vaccine a reality?” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 16, no. 6, pp. 889–900, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Cheng, P. Jain, S. Pal et al., “Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A, (AtpA) (TC0582),” Microbes and Infection, vol. 16, no. 2, pp. 123–133, 2014. View at Publisher · View at Google Scholar
  8. A. W. Olsen, P. Andersen, and F. Follmann, “Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model,” Vaccine, vol. 32, no. 6, pp. 685–692, 2014. View at Publisher · View at Google Scholar
  9. R. C. Brunham and R. Rappuoli, “Chlamydia trachomatis control requires a vaccine,” Vaccine, vol. 31, no. 15, pp. 1892–1897, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. D. LaVerda, L. N. Albanese, P. E. Ruther et al., “Seroreactivity to Chlamydia trachomatis Hsp10 correlates with severity of human genital tract disease,” Infection and Immunity, vol. 68, no. 1, pp. 303–309, 2000. View at Google Scholar · View at Scopus
  11. R. Punnonen, P. Terho, V. Nikkanen, and O. Meurman, “Chlamydial serology in infertile women by immunofluorescence,” Fertility and Sterility, vol. 31, no. 6, pp. 656–659, 1979. View at Google Scholar · View at Scopus
  12. R. C. Brunham, R. Peeling, I. Maclean, M. L. Kosseim, and M. Paraskevas, “Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates,” Journal of Infectious Diseases, vol. 165, no. 6, pp. 1076–1081, 1992. View at Google Scholar · View at Scopus
  13. Y.-X. Zhang, S. Stewart, T. Joseph, H. R. Taylor, and H. D. Caldwell, “Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis,” Journal of Immunology, vol. 138, no. 2, pp. 575–581, 1987. View at Google Scholar · View at Scopus
  14. E. M. Peterson, G. M. Zhong, E. Carlson, and L. M. de la Maza, “Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity,” Infection and Immunity, vol. 56, no. 4, pp. 885–891, 1988. View at Google Scholar · View at Scopus
  15. G. Zhong, J. Berry, and R. C. Brunham, “Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis,” Infection and Immunity, vol. 62, no. 5, pp. 1576–1583, 1994. View at Google Scholar · View at Scopus
  16. S. Pal, I. Theodor, E. M. Peterson, and L. M. de la Maza, “Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge,” Vaccine, vol. 15, no. 5, pp. 575–582, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. R. C. Brunham, C. C. Kuo, L. Cles, and K. K. Holmes, “Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix,” Infection and Immunity, vol. 39, no. 3, pp. 1491–1494, 1983. View at Google Scholar · View at Scopus
  18. R. C. Brunham and R. W. Peeling, “Chlamydia trachomatis antigens: role in immunity and pathogenesis,” Infectious Agents and Disease, vol. 3, no. 5, pp. 218–233, 1994. View at Google Scholar · View at Scopus
  19. R. W. Peeling, J. Kimani, F. Plummer et al., “Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease,” Journal of Infectious Diseases, vol. 175, no. 5, pp. 1153–1158, 1997. View at Google Scholar · View at Scopus
  20. J. Kimani, I. W. Maclean, J. J. Bwayo et al., “Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya,” Journal of Infectious Diseases, vol. 173, no. 6, pp. 1437–1444, 1996. View at Google Scholar · View at Scopus
  21. F. O. Eko, W. Lubitz, L. McMillan et al., “Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis,” Vaccine, vol. 21, no. 15, pp. 1694–1703, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Finco, E. Frigimelica, F. Buricchi et al., “Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 24, pp. 9969–9974, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. L. Patel, D. Sachdev, P. Nagpal et al., “Prevalence of Chlamydia infection among women visiting a gynaecology outpatient department: evaluation of an in-house PCR assay for detection of Chlamydia trachomatis,” Annals of Clinical Microbiology and Antimicrobials, vol. 9, article 24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Sachdeva, A. L. Patel, D. Sachdev, M. Ali, A. Mittal, and D. Saluja, “Comparison of an in-house PCR assay, direct fluorescence assay and the Roche AMPLICOR Chlamydia trachomatis kit for detection of C. trachomatis,” Journal of Medical Microbiology, vol. 58, no. 7, pp. 867–873, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. L. Patton, Y. C. Sweeney, N. J. Bohannon et al., “Effects of doxycycline and antiinflammatory agents on experimentally induced chlamydial upper genital tract infection in female macaques,” Journal of Infectious Diseases, vol. 175, no. 3, pp. 648–654, 1997. View at Google Scholar · View at Scopus
  26. S. Saha and G. P. Raghava, “Prediction of continuous B-cell epitopes in an antigen using recurrent neural network,” Proteins: Structure, Function, and Bioinformatics, vol. 65, no. 1, pp. 40–48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. H. J. Dechamma, V. Dighe, C. A. Kumar, R. P. Singh, M. Jagadish, and S. Kumar, “Identification of T-helper and linear B epitope in the hypervariable region of nucleocapsid protein of PPRV and its use in the development of specific antibodies to detect viral antigen,” Veterinary Microbiology, vol. 118, no. 3-4, pp. 201–211, 2006. View at Publisher · View at Google Scholar
  28. W. J. Newhall, B. Batteiger, and R. B. Jones, “Analysis of the human serological response to proteins of Chlamydia trachomatis,” Infection and Immunity, vol. 38, no. 3, pp. 1181–1189, 1982. View at Google Scholar · View at Scopus
  29. W. Baehr, Y.-X. Zhang, T. Joseph et al., “Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 11, pp. 4000–4004, 1988. View at Google Scholar · View at Scopus
  30. D. E. Kawa, J. Schachter, and R. S. Stephens, “Immune response to the Chlamydia trachomatis outer membrane protein PorB,” Vaccine, vol. 22, no. 31-32, pp. 4282–4286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. R. S. Stephens, E. A. Wagar, and G. K. Schoolnik, “High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis,” Journal of Experimental Medicine, vol. 167, no. 3, pp. 817–831, 1988. View at Google Scholar · View at Scopus
  32. R. C. Brunham, D. J. Zhang, X. Yang, and G. M. McClarty, “The potential for vaccine development against chlamydial infection and disease,” Journal of Infectious Diseases, vol. 181, supplement 3, pp. S538–S543, 2000. View at Google Scholar · View at Scopus
  33. J. U. Igietseme, C. M. Black, and H. D. Caldwell, “Chlamydia vaccines: strategies and status,” BioDrugs, vol. 16, no. 1, pp. 19–35, 2002. View at Google Scholar · View at Scopus
  34. J. Schachter, “Overview of Chlamydia trachomatis infection and the requirements for a vaccine,” Reviews of Infectious Diseases, vol. 7, no. 6, pp. 713–716, 1985. View at Google Scholar · View at Scopus
  35. J. T. Grayston, S. P. Wang, L. J. Yeh, and C. C. Kuo, “Importance of reinfection in the pathogenesis of trachoma,” Reviews of Infectious Diseases, vol. 7, no. 6, pp. 717–725, 1985. View at Google Scholar · View at Scopus
  36. R. C. Brunham, F. A. Plummer, and R. S. Stephens, “Bacterial antigenic variation, host immune response, and pathogen-host coevolution,” Infection and Immunity, vol. 61, no. 6, pp. 2273–2276, 1993. View at Google Scholar · View at Scopus
  37. I. Portig, J. C. Goodall, R. L. Bailey, and J. S. H. Gaston, “Characterization of the humoral immune response to Chlamydia outer membrane protein 2 in chlamydial infection,” Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 1, pp. 103–107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. S. S. Witkin, J. Jeremias, M. Toth, and W. J. Ledger, “Proliferative response to conserved epitopes of the Chlamydia trachomatis and human 60-kilodalton heat-shock proteins by lymphocytes from women with salpingitis,” American Journal of Obstetrics & Gynecology, vol. 171, no. 2, pp. 455–460, 1994. View at Google Scholar · View at Scopus
  39. C. Tan, R. C. Hsia, H. Shou et al., “Chlamydia trachomatis-infected patients display variable antibody profiles against the nine-member polymorphic membrane protein family,” Infection and Immunity, vol. 77, no. 8, pp. 3218–3226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. E. A. Wagar, J. Schachter, P. Bavoil, and R. S. Stephens, “Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens,” Journal of Infectious Diseases, vol. 162, no. 4, pp. 922–927, 1990. View at Google Scholar · View at Scopus
  41. A. Verma and A. T. Maurelli, “Identification of two eukaryote-like serine/threonine kinases encoded by Chlamydia trachomatis serovar L2 and characterization of interacting partners of Pkn1,” Infection and Immunity, vol. 71, no. 10, pp. 5772–5784, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Sharma, Y. Zhong, F. Dong, J. M. Piper, G. Wang, and G. Zhong, “Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins,” Infection and Immunity, vol. 74, no. 3, pp. 1490–1499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. D. D. Rockey, R. A. Heinzen, and T. Hackstadt, “Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells,” Molecular Microbiology, vol. 15, no. 4, pp. 617–626, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. J. P. Bannantine, W. E. Stamm, R. J. Suchland, and D. D. Rockey, “Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates,” Infection and Immunity, vol. 66, no. 12, pp. 6017–6021, 1998. View at Google Scholar · View at Scopus